News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DiaKine Therapeutics, Inc. And Mediatech, Inc. To Market Immune Modulating Media Designed To Improve Islet Cell Transplants


1/10/2007 12:16:17 PM

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--DiaKine Therapeutics, Inc. and Mediatech, Inc. today announced an agreement to market Lisofylline (LSF) to islet cell transplant centers worldwide. LSF is designed to improve the viability and insulin producing capabilities of harvested islet cells prior to transplant, potentially improving the success rate of the procedure.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES